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Modest serum creatinine elevation affects adverse outcome tive risk stratification may improve clinical care, as well
after general surgery. as the process of informed consent. In addition, identifi-
Background. Modest preoperative serum creatinine eleva- cation of risk factors for adverse outcome can lead totion (1.5 to 3.0 mg/dL) has been recently shown to be indepen-
better risk-adjustment models for examining variationdently associated with morbidity and mortality after cardiac
in quality of care [1–4].surgery. It is important to know if this association can be ap-
plied more broadly to general surgery cases. Most attention has focused on preoperative evaluation
Methods. Multivariable logistic regression analyses of 46 risk designed to detect risk for cardiac or pulmonary compli-
variables in 49,081 cases from the Veterans Affairs National Sur- cations [5–12]. Such factors as surgical priority, type ofgical Quality Improvement Program, undergoing major general
surgery, and cardiopulmonary and functional status havesurgery from 10/1/96 through 9/30/98.
served as the basis for assessing postoperative cardiac com-Results. Thirty day mortality and several cardiac, respira-
tory, infectious and hemorrhagic morbidities were significantly plication risk [5–12]. Analyses of several widely used
(P0.001) higher in patients with a serum creatinine1.5mg/dL. existing methods to predict postoperative cardiac risk
With multivariable analysis, the adjusted odds ratio for mortal-
suggest a need for improved risk prediction modelsity for patients with a serum creatinine of 1.5 to 3.0 mg/dL was
[10, 11]. For example, modest serum creatinine elevation1.44 [95% confidence interval (95% CI) 1.22 to 1.71] and for
creatinine 3.0 mg/dL was 1.93 (95% CI 1.51 to 2.46). The ad- (1.5 to 3.0 mg/dL) has been recently shown to be inde-
justed odds ratio for morbidity (one or more postoperative pendently associated with cardiac complication risk, as
complications) for patients with a serum creatinine of 1.5 to well as other postoperative complications and mortality
3.0 mg/dL was 1.18 (95% CI 1.06 to 1.32) and for creatinine
after cardiac surgery [13, 14]. Currently, at least 3 million3.0 mg/dL was 1.19 (95% CI 0.99 to 1.43). Further stratifica-
Americans are estimated to have a serum creatinine oftion and recursive partitioning of creatinine levels revealed
that a serum creatinine level 1.5 mg/dL was the approximate 1.7 mg/dL or higher [15, 16]. The association between
threshold for both increased morbidity and mortality. modest creatinine elevations and poor outcomes from
Conclusions. Modest preoperative serum creatinine eleva- cardiac surgery may be related to the intensity of thetion (1.5 mg/dL) is a significant predictor of risk-adjusted
operation. The present analysis was done to determinemorbidity and mortality after general surgery. A preoperative
whether the findings that modest serum creatinine eleva-serum creatinine of 1.5 mg/dL or higher is a readily available
marker for potential adverse outcomes after general surgery. tion is a predictor of adverse outcomes following cardiac
surgery can be applied more broadly to general surgery.
To test this hypothesis, we examined operative outcomes
More than 30 million patients undergo non-cardiac of 49,081 patients undergoing major general surgical pro-
surgery annually in the United States. In patients under- cedures at 100 Department of Veterans Affairs (VA)
going general surgery, preoperative assessment seeks to medical centers across the United States.
determine if both inherent and modifiable risk factors
for adverse operative outcomes are present. Preopera-
METHODS
Study population
Key words: creatinine, postoperative mortality, morbidity, surgery risk
factors, preoperative assessment. Based on the Continuous Improvement in Cardiac Sur-
gery Program [17] (CICSP) and the National VA Surgi-Received for publication September 18, 2001
cal Risk Study [1–3], the VA National Surgical Qualityand in revised form February 21, 2002
Accepted for publication March 22, 2002 Improvement Program (NSQIP) was established in 1994.
For non-cardiac surgery, this is the first validated, com- 2002 by the International Society of Nephrology
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prehensive, national outcome-based, and peer-controlled risk variables included in the analyses were missing in
less than 1.6% of cases, except for platelet count (3.8%program for measuring and improving quality of surgical
care [18]. NSQIP surgical nurse reviewers collect exten- missing) and serum albumin (38.5% missing). Cases
missing either of these latter values were first categorizedsive preoperative, intraoperative, and postoperative data
on patients undergoing non-cardiac operations at 123 by their serum creatinine value, and then the respective
median value for the missing lab result was assigned toVA medical centers across the United States. More de-
tailed information about the NSQIP study has been pub- that case. Since all other risk variables were missing in
very few cases (1.6%), these missing values were im-lished previously [1–3, 18].
All patients undergoing major general surgery opera- puted to their respective reference group values.
tions in the NSQIP database between October 1, 1996
Statistical analysisand September 30, 1998 were eligible for this study, as
it contained the most recent data available [1]. In order To examine possible bias due to omitting cases with
missing serum creatinine, comparisons of preoperativeto reduce confounding effects to increase poor outcome
and to be consistent with NSQIP analytic practices, cases risk factors and outcomes were made between cases with
a documented preoperative serum creatinine and caseswith a subsequent general surgical procedure performed
within 30 days of the index procedure (3640 cases) were missing creatinine, using either a chi-square test (cate-
gorical variables) or a nonparametric Kruskal-Wallis testexcluded. Of 62,231 cases identified, 13,129 (21%) were
eliminated from further analysis because they lacked (continuous variables) [22].
Statistical analyses were performed to compare differ-documentation of a preoperative serum creatinine level.
An additional 21 cases were eliminated due to missing ences in preoperative risks, mortality, and morbidity be-
tween the three groups of cases categorized by serummore than 50% of the preoperative risk variables. The
final study population consisted of 49,081 cases. creatinine concentration. For risk model development,
the data were randomly and evenly split into a learning
End points and preoperative risk factors set (for building a model) and test set (to test the model),
one for each of the two outcomes. Employing stepwiseTwo major outcomes were analyzed in this study: (1)
death due to any cause within 30 days of the operation selection, multivariate logistic regression [23] was per-
formed on each learning dataset (for mortality and mor-(30-day mortality), and (2) the occurrence of one or
more of 21 major morbidities within 30 days of the opera- bidity), allowing all preoperative risk variables other
than serum creatinine, to be candidate variables sincetion (30-day morbidity). The use of a binary outcome
(none vs. one or more morbidities) to assess risk-adjusted the number of outcomes was sufficiently large [24]. The
models were then applied to the test data, where themorbidity has been validated previously [3, 19].
Prior to data analysis, cases were stratified by three risk of death and risk of morbidity were calculated for
every case. C-indices [25] were calculated on test datalevels of preoperative serum creatinine concentration:
(1) less than 1.5 mg/dL (normal value for most hospital for these models, and minus two log likelihood (2LL)
values were noted [26].laboratories), (2) 1.5 to 3.0 mg/dL inclusive (consistent
with mild to moderate renal insufficiency, usually asymp- The three-level serum creatinine variable was subse-
quently added to each risk model (using test data) totomatic), and (3) greater than 3.0 mg/dL (indicative of
advanced renal insufficiency) [20, 21]. No data on creati- evaluate the independent effect on mortality and mor-
bidity. The logistic transformation of the mortality/mor-nine clearance were obtained, and a more detailed analy-
sis (such as use of the Cockcroft-Gault nomogram) of bidity risk estimate was used as an offset so that initial
risk parameters would not be re-estimated, leaving therenal function was not available from the database.
There were 46 preoperative risk factors in the study originally estimated probability of risk intact. The2LL
was noted and the likelihood ratio test [26] was used todata, details of which have been previously published
[1]. Seven neurologically-based risks were combined into assess improvement in the full models (with creatinine)
over the reduced models (without creatinine), since it isone variable indicating any neurologic dysfunction. Oth-
ers were eliminated because of high numbers of missing the preferred method of assessing statistical significance
of creatinine in a nested model [24–26]. C-indices also(test not done) values (alkaline phosphatase, bilirubin,
BUN, prothrombin time, partial thromboplastin time, were calculated for each model.
To estimate the threshold value of preoperative serumSGOT), unreliability documented by NSQIP (redo oper-
ation), close relationship with wound infection (wound creatinine that increases risk-adjusted mortality and mor-
bidity, recursive partitioning was performed using CARTclassification), and collinearity with creatinine (preoper-
ative dialysis, acute renal failure). American Society of software (Version 3.63; Salford Systems, San Diego, CA,
USA) on all 49,081 cases, using observed outcomes [27, 28].Anesthesiologists (ASA) class also was eliminated be-
cause it represents a composite ranking based on other To confirm these thresholds, Cramer’s V [29] tests and fur-
ther regression analyses were performed. Cramer’s V ispreoperative risk factors also in initial study models. All
O’Brien et al: Serum creatinine and operative outcome 587
a chi-square measure that reflects the strength of associa- gent surgery. Cases with higher serum creatinine also pre-
sented more often with ascites, bleeding disorders, pneu-tion between two variables, ranging in value from 0 (no
association) to 1 (perfect association). Further regression monia, neurologic deficits, diabetes, dependent func-
tional status, recent congestive heart failure, a history ofanalyses were done by additional stratification of creati-
nine when added to the reduced model, and the use of COPD, corticosteroid use, and ventilator dependence, as
well as an abnormal serum albumin, hematocrit, plateletcontrast statements [30] to directly compare groupings
of creatinine concentration. count, white blood cell count and sodium concentrations,
than those with a preoperative serum creatinine concen-Since renal failure results in physiologic abnormalities
that have been shown to predispose patients to postoper- tration of 1.5 mg/dL. Mortality and morbidity, as well
as individual postoperative complications, were alsoative complications of bleeding, infections, cardiac com-
plications, and respiratory complications [15, 16], further more prevalent in cases with a preoperative serum creati-
nine concentration 1.5 mg/dL.analyses were performed for these individual morbidit-
ies. Separate models were built for individual morbidity Multivariate modeling performed on the learning data
set showed that three preoperative risk factors (ETOHoutcomes of cardiac arrest, respiratory complications (re-
intubation or ventilator use for more than 48 hours post- use, steroid use, and transfusions of 4 units) out of 28
were not statistically significant for predicting 30-dayoperatively), infections (pneumonia, urinary tract infec-
tion, or deep wound infection), bleeding (requiring 4 mortality, and five risk factors (pneumonia, disseminated
cancer, DNR order, ventilator dependent, and serumunits of packed red blood cells postoperatively), and
systemic sepsis. Serum creatinine was added to each risk sodium) were not statistically significant for predicting
30-day morbidity. Table 2 shows the significant risk vari-model with the logistic transformation of the risk esti-
mate as an offset, to assess its independent effect. Further ables for both initial models and their respective odds
ratio with a 95% confidence interval (95% CI).regression analyses were again utilized in an attempt
to better understand the respective threshold effect of The three-level serum creatinine variable was subse-
quently added to the mortality risk model and the mor-creatinine.
bidity risk model, using the logistic transformation ofAll analyses in this study other than recursive parti-
the previously derived respective risk estimates as antioning were performed using SAS (Version 6.12; SAS
offset. In both models, creatinine was statistically sig-Institute Inc., Cary, NC, USA) software.
nificant (P 0.01). The adjusted odds ratio for mortality
for patients with a serum creatinine of 1.5 to 3.0 mg/dL
RESULTS was 1.44 (95% CI 1.22 to 1.71) and for creatinine
In evaluating differences between those cases with doc- 3.0 mg/dL was 1.93 (95% CI 1.51 to 2.46). The adjusted
umented preoperative serum creatinine and those with- odds ratio for morbidity for patients with a serum creati-
out creatinine documented (cases excluded from study), nine of 1.5 to 3.0 mg/dL was 1.18 (95% CI 1.06 to 1.32)
patient risk factors and outcomes were analyzed. Com- and for creatinine 3.0 mg/dL was 1.19 (95% CI 0.99
pared to the study population, excluded cases were sig- to 1.43). The c-index for the full models (with creatinine)
nificantly younger (58.9 vs. 61.5 years; P 0.001) and less was 0.906 for mortality and 0.765 for morbidity, which
likely to have general anesthesia (69 vs. 77%). Excluded was marginally increased from the reduced models (0.905
cases also had less frequent (all with P  0.005) emer- and 0.764 for mortality and morbidity), although the
gency surgery (8 vs. 15%), neurologic disorder (4 vs. 13%), difference was statistically significant for mortality. The
history of severe COPD (11 vs. 15%), and history of likelihood ratio was significant for both mortality and
congestive heart failure in the month prior to surgery morbidity (P  0.01), indicating that the inclusion of
(1 vs. 3%). Excluded cases also had significantly lower serum creatinine added significantly to each respective
unadjusted mortality (1.8 vs. 4.4%) and morbidity (6.3 original risk model.
vs. 14.2%; P  0.001) rates than included cases. Clearly, To explore the threshold at which an increase in preop-
cases excluded due to a lack of preoperative serum creati- erative serum creatinine is associated with an increase
nine were less severely ill than the cohort of cases in- in mortality and morbidity, additional analyses were con-
cluded in our analysis. ducted on the entire data. Recursive partition analysis,
In the study population, 87% of cases had a preopera- Cramer’s V test, and further regression analyses each
tive serum creatinine level less than 1.5 mg/dL, 10% be- yielded a level of 1.5 mg/dL for morbidity, while the
tween 1.5 and 3.0 mg/dL inclusively, and 3% greater threshold levels yielded for mortality were 1.5, 1.7, and
than 3.0 mg/dL. Table 1 depicts selected preoperative 1.4 mg/dL, respectively, for each method. Figure 1 de-
patient risks and outcomes in cases stratified by preoper- picts unadjusted mortality and morbidity odds ratios for
ative serum creatinine concentration. Cases with higher 0.1 mg/dL increments of preoperative serum creatinine
preoperative serum creatinine were older, more often levels. A steeper slope is noted at approximately 1.6 to
1.7 mg/dL for mortality odds ratios, and rises significantlymale, of non-white race and more often underwent emer-
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Table 1. Characteristics of study patients grouped by pre-operative serum creatinine concentration
Pre-operative serum creatinine concentration mg/dL
Variable 1.5 (N  42,822) 1.5–3.0 (N  4945) 3.0 (N  1314) P value
Patient risks
Mean creatinine mg/dL 1.0 1.9 6.0 0.001
Median creatinine mg/dL 1.0 1.7 5.1 0.001
Mean age years 60.7 68.4 64.1 0.001
Non-white race % 28 31 44 0.001
Male gender % 96 99 98 0.001
ASA class III or IV % 9 28 51 0.001
Ascites % 1 4 5 0.001
Bleeding disorder % 2 4 8 0.001
Chronic dialysis therapy % 1 1 49 0.001
Congestive heart failurea % 2 9 14 0.001
Corticosteroid use % 3 5 6 0.001
Functionally dependent % 11 24 28 0.001
Diabetes mellitus % 15 27 31 0.001
Do not resuscitate order % 1 3 5 0.001
Dyspnea % 15 26 27 0.001
Emergency surgery % 13 28 36 0.001
Neurologic deficit % 11 23 27 0.001
Pneumonia % 1 4 7 0.001
Severe COPDb history % 14 21 18 0.001
Smoker within 1 year % 37 28 30 0.001
Ventilator dependent % 1 5 10 0.001
Weight loss 10%/6 months % 7 7 8 0.009
2 alcoholic drinks/day c % 12 8 8 0.001
Serum albumin 3.5 % 34 54 73 0.001
Hematocrit 35 or 45 % 42 53 73 0.001
Platelets 150 or 400,000 % 19 26 31 0.001
White blood cells 4000 or 10,000 % 17 41 57 0.001
Serum sodium 135 % 10 15 20 0.001
Post-operative outcomes
30-day mortality % 3.1 11.4 19.9 0.001
30-day morbidity % 12.4 25.2 31.0 0.001
Median postop LOSd days 5.0 7.0 9.0 0.001
Cardiac arrest % 0.8 2.5 4.5 0.001
On ventilator 48 hours % 2.0 7.3 11.0 0.001
Re-intubation % 1.7 4.3 4.6 0.001
Pulmonary embolism % 0.1 0.2 0.1 0.836
4 units blood transfused % 0.5 1.4 3.0 0.001
Superficial infection % 2.5 3.0 2.1 0.083
Sepsis % 1.2 3.6 6.5 0.001
Pneumonia % 2.5 4.9 5.7 0.001
a Congestive heart failure (CHF) in the month before surgery
b COPD, chronic obstructive pulmonary disease
c2 alcoholic drinks/day for 2 weeks before surgery
d LOS, length of stay
after 1.9 mg/dL, while the morbidity odds ratio curve piratory complications, 2.0 mg/dL for sepsis, 2.5 mg/dL
rises at a much slower rate after an increase in the slope for cardiac arrest and 3.0 mg/dL for bleeding compli-
between 1.3 to 1.4 and 1.6 to 1.7 mg/dL. cations.
To assess whether modest elevation of serum cre- Because of the potential concern that including dial-
atinine was associated with specific postoperative com- ysis patients in this analysis could bias results, all analy-
plications previously reported with renal insufficiency, ses were repeated after eliminating 729 cases reporting
multivariate models were tested for risk of hemorrhage, preoperative dialysis therapy. While P values and odds ra-
cardiac arrest, infection, pulmonary complication, and tios were not identical, the results were consistent through-
sepsis. Serum creatinine added significantly to the preop- out all analyses, and the approximate threshold values
erative risk models for each of the five individual out- of 1.5 mg/dL for both mortality and morbidity remained
comes except for infections. As with overall morbidity unchanged.
and mortality, regression analyses of further stratifica-
tion of creatinine levels were employed to assess the ap-
DISCUSSIONproximate threshold of serum creatinine that changes its
The results of the present study suggest that modesteffect on individual morbidities (Table 3). The respective
thresholds found were approximately 1.5 mg/dL for res- preoperative serum creatinine elevation (1.5 to 3.0 mg/dL)
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Table 2. Significant risk variables with adjusted odds ratio for mortality or morbidity, without serum creatinine
Adjusted odds ratio (95% confidence interval)
Risk variable Mortality model Morbidity model
Age 1.046 (1.039, 1.053) 1.023 (1.020, 1.027)
Female gender 0.410 (0.213, 0.791) 0.698 (0.540, 0.901)
Emergency surgery 2.331 (1.992, 2.729) 1.928 (1.746, 2.128)
Severe COPDa history 1.308 (1.104, 1.550) 1.219 (1.097, 1.354)
CHF in month before surgery 1.400 (1.102, 1.778) 1.322 (1.111, 1.574)
Dependent functional status 1.436 (1.219, 1.693) 1.361 (1.225, 1.512)
Ascites 3.542 (2.660, 4.716) 1.467 (1.155, 1.863)
Corticosteroid use NS (P  0.05) 1.305 (1.088, 1.565)
Neurologic deficit 1.613 (1.371, 1.896) 1.305 (1.175, 1.449)
2 alcoholic drinks/day for 2 weeks NS (P  0.05) 1.147 (1.016, 1.295)
Bleeding disorder 1.492 (1.124, 1.981) 1.325 (1.066, 1.647)
Anesthesia type
General reference reference
Epidural/spinal 0.581 (0.458, 0.737) 0.320 (0.279, 0.367)
Other 0.081 (0.020, 0.329) 0.113 (0.070, 0.184)
Pneumonia 1.470 (1.127, 1.916) NS (P  0.05)
Disseminated cancer 3.137 (2.463, 3.994) NS (P  0.05)
“Do not resuscitate” order 2.451 (1.857, 3.236) NS (P  0.05)
Dyspnea 1.220 (1.030, 1.444) 1.300 (1.173, 1.440)
4 units RBC pre-operatively NS (P  0.05) 1.618 (1.320, 1.983)
Ventilator dependent 1.730 (1.325, 2.260) NS (P  0.05)
Weight loss 10% last 6 months 1.648 (1.360, 1.997) 1.368 (1.206, 1.551)
Hematocrit %
Normal (35–45) reference reference
Mildly low (30–35) 1.462 (1.215, 1.759) 1.303 (1.168, 1.454)
Severely low (30) 1.708 (1.398, 2.086) 1.380 (1.209, 1.575)
Mildly high (45–50) 0.969 (0.725, 1.296) 0.788 (0.694, 0.895)
Severely high (50) 1.260 (0.755, 2.104) 0.812 (0.622, 1.061)
Platelet count 1000/mm3
Normal (150–400) reference reference
Mildly low (50–150) 1.591 (1.315, 1.925) 0.921 (0.812, 1.045)
Severely low (50) 5.512 (2.990, 10.161) 0.971 (0.574, 1.642)
Mildly high (400–600) 0.774 (0.592, 1.011) 1.070 (0.919, 1.247)
Severely high (600) 0.549 (0.281, 1.072) 0.567 (0.380, 0.845)
White blood cell count 1000/mm3
Normal (4–10) reference reference
Mildly low (2–4) 1.188 (0.804, 1.756) 1.192 (0.949, 1.496)
Severely low (2) 1.966 (0.682, 5.666) 1.163 (0.531, 2.544)
Mildly high (10–15) 1.227 (1.024, 1.471) 1.068 (0.962, 1.185)
Severely high (15) 1.823 (1.492, 2.227) 1.397 (1.225, 1.594)
Serum sodium mmol/L
Normal (135) reference NS (P  0.05)
Mildly abnormal (130–135) 1.326 (1.103, 1.594)
Severely abnormal (130) 1.404 (0.984, 2.001)
Serum albumin g/dL
Normal (3.5) reference reference
Mildly abnormal (3.0–3.5) 1.733 (1.413, 2.124) 1.420 (1.275, 1.582)
Severely abnormal (3.0) 2.836 (2.343, 3.433) 1.698 (1.513, 1.906)
a COPD is chronic obstructive pulmonary disease
is significantly and independently associated with in- plications appeared to occur with only slight elevation
of serum creatinine while values 3.0 mg/dL were re-creased morbidity and mortality after general surgery.
These study results also provide new information as to quired for an independent association with postoperative
hemorrhage to be demonstrated.threshold levels of preoperative serum creatinine that are
associated with adverse operative outcome. Three statis- Our results are consistent with studies from smaller,
more selected patient populations. Browner et al foundtical analytic methods (recursive partitioning, Cramer’s
V, and further regression analyses) all yielded a thresh- that a reduced estimated creatinine clearance was a sig-
nificant (odds ratio 6.8; 95% CI 2.8 to 16.0), independentold serum creatinine value of approximately 1.5 mg/dL
for excess morbidity and mortality. Moreover, we found predictor of postoperative mortality in 474 male veterans
undergoing non-cardiac surgery [31]. An analysis of nearlya “hierarchy of susceptibility” as to the magnitude of ele-
vation of preoperative serum creatinine and type of post- 3000 patients undergoing non-cardiac surgery found that
a preoperative serum creatinine of 2.0 mg/dL was theoperative complication. For example, respiratory com-
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Fig. 1. Mortality () and morbidity () odds
ratios for serum creatinine levels between 1.0
mg/dL and 3.0 mg/dL.
Table 3. Multivariate risk-adjusted odds ratios (95% confidence interval) for preoperative serum creatinine concentrations
relative to serum creatinine 1.5 mg/dL, for selected post-operative morbidities
Post-operative morbidity
Pre-operative Respiratory
serum creatinine Sepsis complications Cardiac arrest Hemorrhage
1.5–2.0 mg/dL 1.14 (0.90, 1.44) 1.42 (1.22, 1.64) 1.00 (0.76, 1.32) 1.34 (0.94, 1.91)
2.0–2.5 mg/dL 1.62 (1.18, 2.22) 1.39 (1.11, 1.75) 1.28 (0.87, 1.88) 1.57 (0.97, 2.54)
2.5–3.0 mg/dL 2.14 (1.53, 2.99) 1.60 (1.23, 2.07) 1.52 (1.01, 2.29) 1.18 (0.63, 2.21)
3.0 mg/dL 1.83 (1.43, 2.33) 1.58 (1.31, 1.89) 1.56 (1.16, 2.08) 1.71 (1.20, 2.45)
single variable associated with the greatest likelihood of tude of our observed association of mild renal insuffi-
ciency with adverse operative outcome could be under-a major cardiac complication [5]. In two recent studies,
we have found that a serum creatinine between 1.5 and estimated. Unfortunately, weight information was not
available so we could not more precisely estimate glo-3.0 mg/dL was significantly and independently associated
with excess mortality and morbidity, similar to those merular filtration rate by published formulas. Also, our
results do not provide any pathophysiologic insights asobserved in the present study, after coronary artery by-
pass grafting and other types of cardiac surgery [13, 14]. to why modest creatinine elevation is independently as-
sociated with operative mortality and several postopera-We should note some of the limitations of our analyses.
First, our results may not be generalizable to non-VA tive morbidities. It is tempting to speculate that such
factors known to be associated with impaired renal func-populations, particularly women. Also, our results are ex-
clusively observational in nature. This observational na- tion, such as decreased excretion of volume loads and
pharmacologic agents and impaired platelet function,ture of our study, however, provides a more representa-
tive view of the population undergoing major surgical could contribute to enhanced respiratory complications
and bleeding respectively. Further studies are requiredprocedures within the VA population than reported with
other study designs, such as randomized controlled trials to ascertain the precise mechanism(s) underlying the
association of renal dysfunction and operative mortalityin which patients are often highly selected.
Second, the use of a discretionary definition to catego- and morbidity.
Finally, the inclusion criteria of having a preoperativerize the presence and degree of renal failure may have
resulted in the inclusion of some patients with a serum baseline serum creatinine concentration available ap-
pears to have resulted in selection of a higher risk popula-creatinine concentration less than 1.5 mg/dL that in fact
had mild to moderate renal failure. Dependent on the tion for study. Approximately 21% of eligible patients,
excluded for no baseline serum creatinine determination,number of cases for which this may hold true, the magni-
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tinuous Improvement in Cardiac Surgery Program Expansion Projectdemonstrated preoperative co-morbidity as well as post-
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